These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28331872)

  • 1. Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer.
    Seeley TW; Sternlicht MD; Klaus SJ; Neff TB; Liu DY
    Hypoxia (Auckl); 2017; 5():1-9. PubMed ID: 28331872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
    Oshima RG; Lesperance J; Munoz V; Hebbard L; Ranscht B; Sharan N; Muller WJ; Hauser CA; Cardiff RD
    Cancer Res; 2004 Jan; 64(1):169-79. PubMed ID: 14729621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
    Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.
    Del Vecchio L; Locatelli F
    Expert Opin Investig Drugs; 2018 Jul; 27(7):613-621. PubMed ID: 29975110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase.
    Yum S; Jeong S; Kim D; Lee S; Kim W; Yoo JW; Kim JA; Kwon OS; Kim DD; Min DS; Jung Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
    Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
    Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
    Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells.
    Asikainen TM; Ahmad A; Schneider BK; Ho WB; Arend M; Brenner M; Günzler V; White CW
    Free Radic Biol Med; 2005 Apr; 38(8):1002-13. PubMed ID: 15780758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer.
    Boddy JL; Fox SB; Han C; Campo L; Turley H; Kanga S; Malone PR; Harris AL
    Clin Cancer Res; 2005 Nov; 11(21):7658-63. PubMed ID: 16278385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells.
    Hey SM; Jensen P; Ryding M; Martínez Serrano A; Kristensen BW; Meyer M
    Eur J Neurosci; 2019 Feb; 49(4):497-509. PubMed ID: 30471165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
    Poloznikov AA; Nersisyan SA; Hushpulian DM; Kazakov EH; Tonevitsky AG; Kazakov SV; Vechorko VI; Nikulin SV; Makarova JA; Gazaryan IG
    Front Pharmacol; 2020; 11():621054. PubMed ID: 33584306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.